SABINA + Hong Kong: a territory wide study of prescribing trends and outcomes associated with the use of short-acting β2 agonists in the Chinese population.

Autor: Fung LW; formerly, Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; formerly, Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong SAR, China., Yan VK; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Kwan C; Sau Po Centre of Ageing, The University of Hong Kong, Hong Kong SAR, China.; formerly, Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; formerly, Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong SAR, China., Kwok WC; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China., Lam DC; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China., McDonald CF; Department of Respiratory and Sleep Medicine, Austin Health, Melbourne, Australia.; University of Melbourne, Parkville, Melbourne, Victoria, Australia.; Institute for Breathing and Sleep, Heidelberg, Melbourne, Victoria, Australia., Bloom CI; National Heart and Lung Institute, Imperial College London, London, UK., Wong IC; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong SAR, China.; Aston Pharmacy School, Aston University, Birmingham, B4 7ET, UK.; Advanced Data Analytics for Medical Science (ADAMS) Limited, Hong Kong SAR, China., Chan EW; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. ewchan@hku.hk.; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong SAR, China. ewchan@hku.hk.; Department of Pharmacy, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China. ewchan@hku.hk.; The University of Hong Kong Shenzhen Institute of Research and Innovation, Shenzhen, China. ewchan@hku.hk.

Publikováno v: BMC pulmonary medicine [BMC Pulm Med] 2024 May 14; Vol. 24 (1), pp. 232. Date of Electronic Publication: 2024 May 14.

Low-Density Lipoprotein Cholesterol Treatment Target Achievement in Patients with Myocardial Infarction, Percutaneous Coronary Intervention, or Stroke in Hong Kong.

Autor: Blais JE; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; School of Public Health, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China., Yan VK; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China., Zhao J; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; Digital and Data Innovation, AstraZeneca Global R&D (China) Co, Ltd, 200000 Shanghai, China., Chui CS; School of Public Health, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; School of Nursing, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; Laboratory of Data Discovery for Health, Hong Kong Science Park, Sha Tin, Hong Kong SAR, China., Wong IC; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; Laboratory of Data Discovery for Health, Hong Kong Science Park, Sha Tin, Hong Kong SAR, China.; Aston Pharmacy School, Aston University, B4 7ET Birmingham, UK., Siu CW; Division of Cardiology, Department of Medicine, University of Hong Kong, Hong Kong SAR, China., Chan EW; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.; Laboratory of Data Discovery for Health, Hong Kong Science Park, Sha Tin, Hong Kong SAR, China.; Department of Pharmacy, The University of Hong Kong-Shenzhen Hospital, 518000 Shenzhen, GuangDong, China.; The University of Hong Kong Shenzhen Institute of Research and Innovation, 518000 Shenzhen, GuangDong, China.

Publikováno v: Reviews in cardiovascular medicine [Rev Cardiovasc Med] 2022 Sep 26; Vol. 23 (10), pp. 327. Date of Electronic Publication: 2022 Sep 26 (Print Publication: 2022).

Knowledge and Practice on Injection Safety among Primary Health Care Workers in Kaski District, Western Nepal.

Autor: Gyawali S; Department of Pharmacology, Manipal College of Medical Sciences, Pokhara, Kaski, Pin code: 33700, Nepal., Rathore DS; NIMS Institute of Pharmacy, NIMS University, Shobha Nagar, Jaipur-Delhi Highway, Jaipur, Pin code: 303121, India., Shankar PR; Department of Pharmacology, Xavier University School of Medicine, Oranjestad, Aruba, Kingdom of the Netherlands., Kc VK; Department of Statistics, Prithvi Narayan Multiple Campus, Pokhara, Kaski, Pin code 33700, Nepal., Jha N; Department of Clinical Pharmacology and Therapeutics, KIST Medical College, Imadol, Lalitpur, Pin code: 44705, Nepal., Sharma D; Department of Pharmacology, Manipal College of Medical Sciences, Pokhara, Kaski, Pin code: 33700, Nepal.

Publikováno v: The Malaysian journal of medical sciences : MJMS [Malays J Med Sci] 2016 Jan; Vol. 23 (1), pp. 44-55.